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Lymphocyte integrinsmediate cell arrest on endothe-
lium during immune surveillance after activation by
chemokine-stimulated inside-out signals. Here we
show that a Vav1-talin complex in T cells is a key
target for chemokine-triggered inside-out signaling
leading to integrin a4b1 activation. Thus, Vav1 disso-
ciation from talin was required to generate high-
affinity a4b1 conformations. Assembly of the Vav1-
talin complex required PtdIns(4,5)P2, which was
provided by talin-bound phosphatidylinositol phos-
phate kinase Ig. Chemokine-promoted Vav1 dissoci-
ation from talin followed an initial increase in talin
binding to a4b1. This process was dependent on
ZAP-70, which binds to and phosphorylates Vav1 in
the complex, leading to further a4b1 activation and
cell adhesion strengthening. Moreover, Vav1-talin
dissociation was needed for Rac1 activation, thus
indicating that a4b1 and Rac1 activation can be
coupled by chemokine-stimulated ZAP-70 function.
Our data suggest that Vav1 might function as
a repressive adaptor of talin that must dissociate
from a4b1-talin complexes for efficient integrin
activation.INTRODUCTION
Chemokines promote the migration of immune cells from lymph
and blood circulation into lymphoid tissues and sites of inflam-
mation during immune surveillance (Campbell et al., 2003; Charo
and Ransohoff, 2006; Rot and von Andrian, 2004). This process
is achieved after rapid stimulation of a4b1 and aLb2 integrin
activity on T lymphocytes by chemokines presented on the
endothelium. Thus, chemokine binding to G protein-coupled
receptors induces rapid activation of effector molecules that
lead to integrin-mediated upregulation of cell adhesion, a
process called inside-out signaling (Kinashi, 2005; Ley et al.,
2007; Luster et al., 2005). Integrin cytoplasmic regions are
responsible for sensing and transmitting molecular informationIoriginated by this signaling, to finally generate high-affinity
conformations of the integrin extracellular domain.
Talin is a homodimer protein that physically links integrin
b subunits with the actin cytoskeleton (Calderwood, 2004;
Campbell and Ginsberg, 2004; Nayal et al., 2004). The talin
N-terminal head domain contains the FERM (protein 4.1, ezrin,
radixin, and moesin) region that binds to an NPXY or NPXF
membrane-proximal motif in b-subunit cytoplasmic tails (Camp-
bell and Ginsberg, 2004). The FERM region also interacts with
the type I phosphatidylinositol phosphate kinase g90 (PIPKIg90)
(Di Paolo et al., 2002) (also called PIPKIg-661) (Ling et al., 2002),
leading to local accumulation of its product phosphatidylinositol-
4, 5-bisphosphate [PtdIns(4,5)P2)], a phosphoinositide that
stimulates talin-b1 integrin interaction (Martel et al., 2001) by
disrupting the interaction between the head and the C-terminal
rod domain of talin (Goksoy et al., 2008). The talin rod domain
interacts with vinculin and actin, providing links to the actin cyto-
skeleton (Gilmore and Burridge, 1996). Talin is required for
affinity regulation of b1 and b3 integrins (Calderwood et al.,
1999; Nieswandt et al., 2007; Petrich et al., 2007; Tadokoro
et al., 2003; Wegener et al., 2007), and overexpression of the talin
head domain promotes separation of a and b subunit cyto-
plasmic domains (Kim et al., 2003), a key event leading to integrin
activation (Carman and Springer, 2003). Moreover, the chemo-
kine CXCL12 also causes spatial separation of these domains
in aLb2 (Kim et al., 2003), suggesting that talin is a true candidate
for regulation of integrin activation in response to chemokines.
Earlier work reported that talin associates with the guanine-
nucleotide exchange factor (GEF) Vav on mouse T cells (Fischer
et al., 1998), but the functional role of this association was not
addressed. Vav1 is a key component of the inside-out signaling
generated upon binding of CXCL12 to its receptor CXCR4 that
leads to stimulation of a4b1 integrin activation on T lymphocytes
(Garcia-Bernal et al., 2005). Vav1 is a multidomain protein that
functions as GEF predominantly for Rac (Bustelo, 2000; Turner
and Billadeau, 2002). Importantly, it has been demonstrated
that Vav proteins play crucial roles in T cell activation and devel-
opment (Tybulewicz, 2005). Activation of Vav GEF activity
requires phosphorylation at tyrosine residues located on its
acidic domain, whereas the Dbl-homology region is responsible
for GEF activity and the SH2 and SH3 domains interact with
autophosphorylated tyrosine kinases and with several adaptor
proteins (Bustelo, 2000; Turner and Billadeau, 2002). ZAP70,mmunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc. 953
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activated receptors in lymphocytes, including CXCR4 (Ottoson
et al., 2001; Ticchioni et al., 2002; Tybulewicz, 2005).
In the present work we have studied the role of the Vav1-talin
association in chemokine-stimulated T lymphocyte adhesion
mediated by a4b1. In addition, we have investigated the func-
tional cross-talk between PtdIns(4,5)P2 and the molecular
machinery activated during inside-out signaling triggered by
chemokines. We provide evidence that changes in Vav1-talin
association, which are controlled by PtdIns(4,5)P2, are required
for regulation of T cell adhesion mediated by a4b1.
RESULTS
CXCL12 Promotes Vav1-Talin Dissociation that
Is Linked to Stimulation of Vav1 Phosphorylation
Vav1 and talin were found constitutively associated in nonstimu-
lated human Molt-4 T cells and PBL-T lymphocytes (Figures 1A
and 1B). Notably, Vav1-talin association was rapidly reduced
upon cell exposure to CXCL12. Dissociation between Vav1
and talin was independent of a potential protease activity on talin
(Figure S1A available online), and total talin amounts were unal-
tered in cells silenced for Vav1 expression by RNA interference
(Figure 1B, right), indicating that absence of the Vav1-talin asso-
ciation does not lead to talin cleavage. More than 98% of Vav1
and talin proteins were present in the digitonin- or Triton
X-100-soluble fraction after cell lysis (Figure S1B), indicating
that changes in dynamic associations between these molecules
were detected in a relevant fraction of their total cellular popula-
tion. In addition, whereas talin showed a cortical distribution
independently of cell exposure to CXCL12, Vav1 cortical
localization was substantially reduced after incubation with the
chemokine (Figure S1C), suggesting a change in Vav1 subcel-
lular localization resulting from CXCL12 actions.
Vinculin coprecipitated with talin, and concomitant with che-
mokine-promoted Vav1-talin dissociation, vinculin gradually
increased its binding to talin (Figure 1B, left). Talin binding to
vinculin was independent of Vav1, as shown by the fact that
Vav1 silencing did not affect the binding (Figure 1B, right).
Also, although Vav1 antibodies coprecipitated talin, no vinculin
was detected in these immunoprecipitates, and vinculin anti-
bodies coprecipitated talin but not Vav1 (not shown), suggesting
the unlikelihood of Vav1-vinculin interaction.
Vav1 tyrosine phosphorylation was difficult to detect in
Vav1-talin complexes in nonstimulated T cells, and only when
association decreased because of CXCL12 was a clear Vav1
phosphorylation observed (Figures 1A and 1D). Activation of
this phosphorylation was preceded by a gradual increase in
Vav1 coprecipitation with ZAP-70 (Figure 1A), a kinase involved
in Vav1 phosphorylation (Ottoson et al., 2001; Ticchioni et al.,
2002). In addition, we observed that CXCL12 stimulated a tran-
sient Vav1-b1 association in Molt-4 and PBL-T cells (Figure 1A).
Interestingly, when we abolished Vav1-talin association by
silencing talin expression with i-talin siRNA, we found a defective
chemokine-promoted Vav1 tyrosine phosphorylation, as well as
impairment in Rac activation (Figures 1C–1E; Figure S2A). To
determine whether inhibition of Rac activation was directly
dependent on impaired Vav1 activity, we expressed a constitu-
tively active Vav1 form (DCH+Ac-GFP) (Lopez-Lago et al.,954 Immunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc.2000) and analyzed whether Rac activation was restored. With
Vav1 DCH+Ac-GFP transfection efficiencies ranging 35%–
40%, we obtained a partial recovery of Rac activation in talin-
silenced cells, as compared to control (WT) GFP transfectants
(Figure 1F). These data suggest that impairment in Rac activation
after targeting talin involves defective Vav1 phosphorylation, and
possibly Vav1-independent mechanisms.
CXCL12 Stimulates Talin-Integrin b1 Association
With similar kinetics as Vav1-talin disassembly, CXCL12
promoted in Molt-4 and PBL-T cells a rapid and transient
increase in the association of talin with the b1 subunit of a4b1
(Figure 2A, left and middle). As expected, no talin-b1 complexes
were seen in talin-silenced cells (Figure 2A, right), although they
had no alterations in a4b1 heterodimer formation or in a4b1 cell
surface expression (Figure S2B). Importantly, no talin-b1
complexes were detected in Vav1-silenced cells, and CXCL12
was unable to promote the association (Figure 2B), indicating
that talin-b1 binding was dependent on Vav1. Transient Vav1-b1
association triggered by CXCL12 was also confirmed with b1 anti-
bodies, whereas this complex was not formed in Vav1-silenced
cells.
We used CCL21 to investigate whether other chemokines can
also influence Vav1, talin, and b1 associations. CCL21 induced
Vav1 release from talin, which was linked to increased talin-b1
association (Figure 2C), indicating that these dynamic changes
might represent common GPCR-mediated T cell responses
with functional implications. Together, these data indicate that
chemokines regulate associations between Vav1, talin, and b1,
which could have important consequences for a4b1-mediated
T cell attachment.
Talin Is Required for Chemokine-Promoted
a4b1-Dependent T Cell Adhesion
To study whether changes in associations between Vav1, talin,
and b1 could influence T cell attachment mediated by a4b1,
we silenced talin expression and tested transfectant adhesion
to a4b1 ligands. Talin-silenced T cells revealed a partial reduc-
tion in CXCL12-stimulated attachment to VCAM-1 and CS-1-FN
under static conditions, relative to control and ni-talin 1 siRNA
transfectants (Figure S2C).
Flow chamber adhesion assays under shear stress revealed
that CXCL12 triggered a rapid firm attachment to VCAM-1 in
75%–85% of Molt-4 and PBL-T cells transfected with control
or ni-talin 1 siRNA, while a minor transfectant population (5%–
10%) displayed transient arrest (Figure 3A). Control experiments
indicated blocking of adhesion by cell pretreatment with per-
tussis toxin or with a4 mAb (not shown). Instead, i-talin 1 siRNA
transfectants predominantly rolled, displaying low stable arrest
on VCAM-1 that was associated with increased transient attach-
ment, suggesting that talin is required during initial events of
chemokine-triggered a4b1-VCAM-1 interaction. Moreover, con-
trol and ni-talin 1 siRNA transfectants developed higher resis-
tance to detachment at increased shear stress than i-talin
1 siRNA counterparts (Figure 3B). The potential involvement of
talin at initial steps of adhesion was studied by measuring cell
binding of 15/7, a mAb that recognizes a b1 integrin activation
epitope on a4b1 (Yednock et al., 1995), as well as by analyzing
binding of VCAM-1-Fc. 15/7 mAb and VCAM-1-Fc bound
Figure 1. CXCL12 Promotes Vav-Talin Dissociation that Is Linked to Stimulation of Vav1 Phosphorylation
(A) Cells were incubated for the indicated times with CXCL12 (200 ng/ml) and subjected to immunoprecipitation with control (Ctr) or Vav1 antibodies, followed by
immunoblotting with antibodies to the stated proteins.
(B) Lysates from nontransfected (left) or control or Vav1 siRNA-transfected (right) Molt-4 cells were subjected to immunoprecipitation and immunoblotting.
(C) Nontransfected (–) or Molt-4 cells transfected with the indicated noninterfering or interfering talin 1 (ni-talin 1 or i-talin 1, respectively) or with control siRNA
were analyzed by immunoblotting with talin antibodies. Numbers below gels indicate values from densitometer analyses.
(D and E) Control or i-talin 1 siRNA transfectants were incubated with CXCL12 and tested in immunoprecipitation and immunoblotting assays or subjected
to GTPase assays to detect active Rac.
(F) Molt-4 cells were cotransfected with control or i-talin 1 siRNA and wild-type (WT) or constitutively active (DCH+Ac) Vav1 forms and tested in Rac GTPase
assays.
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Figure 2. CXCL12 Stimulates Integrin b1-Talin Association on T Cells
(A and B) Molt-4 and PBL-T cells, or the indicated siRNA transfectants, were incubated with CXCL12 and subjected to immunoprecipitation with control (Ctr)
or anti-b1 followed by immunoblotting with antibodies to the indicated proteins. Numbers below gels indicate values from densitometer analyses.
(C) PBL-T cells were incubated with CCL21 (200 ng/ml) and subjected to immunoprecipitation with anti-Vav1 or anti-b1 and immunoblotting to the stated
proteins.
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Vav1-Talin Dissociation Controls T Cell Adhesionsubstantially less to CXCL12-incubated talin knockdown cells
than control or ni-talin 1 siRNA transfectants (Figures 3C and
3D). Control experiments showed that all transfectants retained
a similar degree of 15/7 mAb or VCAM-1-Fc binding upon expo-
sure to Mn2+, a positive control for integrin affinity regulation
(Figures 3C and 3D). These data indicate that activation of
a4b1 in response to CXCL12 is defective in talin-silenced cells,
which probably accounts for reduced stable T cell tethers and
impaired strengthening of a4b1-VCAM-1 interaction.
ZAP-70 Is Essential for Chemokine-Promoted
Vav1-Talin Dissociation
CXCL12 induces gradual coprecipitation of Vav1 and ZAP-70
concomitant with weakening of Vav1-talin association and
stimulation of Vav1 phosphorylation (Figure 1), so we reasoned
that if dissociation involves ZAP-70 function, perhaps by inhibit-
ing its activity or its expression, we could affect the rate of Vav1-
talin disassembly. Therefore, we incubated T cells with the ZAP-
70 inhibitor piceatannol, or targeted ZAP-70 expression with
siRNA, and we analyzed Vav1-talin complexes in coimmunopre-
cipitation experiments. Whereas cells preincubated with carrier
DMSO or control siRNA transfectants displayed Vav1-talin
dissociation by CXCL12, those exposed to piceatannol or
ZAP-70-silenced cells showed resistance to disassembly of
this complex, which was associated to inhibition by piceatannol
of Vav1 tyrosine phosphorylation without affecting Vav1-ZAP-70
coprecipitation (Figures 4A and 4B). Furthermore, association956 Immunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc.between Vav1 and ZAP-70 required a preformed Vav1-talin
complex, as indicated by the fact that silencing talin prevented
Vav1-ZAP-70 association (Figure 4C). Together with lack of
Vav1 phosphorylation in talin-knockdown cells (Figure 1D), these
results strongly suggest that ZAP-70-dependent Vav1 phos-
phorylation, but not the earlier Vav1-ZAP-70 association, is
required for Vav1 release from talin. Contrary to defective
Vav1-talin dissociation in ZAP-70-silenced cells, talin-b1 or
Vav1-b1 associations stimulated by CXCL12 were not affected
by ZAP-70 knocking down (Figure 4D), indicating that they do
not depend on Vav1-talin disassembly.
Notably, piceatannol-treated or ZAP-70 knockdown T cells
showed a blockade of CXCL12-stimulated adhesion to VCAM-1
(Figure 4E), which arose from defective acquisition of a4b1 active
conformations leading to reduced adhesion strengthening, as
visualized in 15/7 mAb and VCAM-1-Fc binding assays (Fig-
ure 4F; Figure S3). These data indicate that CXCL12 promotes
ZAP-70 binding to Vav1 in Vav1-talin complexes, followed
by stimulation of Vav phosphorylation that leads to reduced
Vav1-talin association, which is essential for progression of
a4b1-mediated T cell adhesion.
PtdIns(4,5)P2-Sequestering Probes Impair Both
Vav1-Talin-b1AssociationsandCellAdhesion toVCAM-1
PtdIns(4,5)P2 stimulates talin binding to the b1 integrin cyto-
plasmic domain (Martel et al., 2001), thereby constituting a
candidate molecule regulating cell adhesion by inside-out
Figure 3. Talin Is Required for Chemokine-Stimulated T Cell Adhesion under Shear Stress Mediated by a4b1
(A and B) Control or talin siRNA transfectants were perfused in flow chambers coated with VCAM-1 immobilized with CXCL12 and analyzed for rolling and
transient or stable cell arrest (A; n = 3) or for cell detachment after increasing shear rates (B; n = 3). Data are presented as indicated in Experimental Procedures.
**Adhesion was significantly inhibited compared to control siRNA transfectant attachment, p < 0.01, or *p < 0.05. DTransient arrest was significantly increased
compared to control siRNA transfectants, p < 0.05.
(C) Molt-4 siRNA transfectants were incubated with or without CXCL12 or Mn2+, followed by incubation with 15/7 or control mAb and analysis by flow cytometry.
(D) siRNA transfectants were preincubated with control or a4 mAb and subsequently incubated in the absence or presence of CXCL12 or Mn2+, before addition of
VCAM-1-Fc. Cell-bound ligand was detected as indicated in Experimental Procedures. Insert numbers represent mean fluorescence intensity units. Represen-
tative results of three independent experiments for (C) and (D) are shown.
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pase C-d1 (PLC-d1) binds PtdIns(4,5)P2 with high affinity (Watt
et al., 2002) and has been used as a GFP-fused form to localize
PtdIns(4,5)P2 and to study the role of this phosphoinositide in
cell adhesion (Downes et al., 2005; Martel et al., 2001; Tall
et al., 2000). We expressed PH-PLC-d1-GFP (PH-GFP) inIMolt-4 cells, which was predominantly found in the cell
membrane fraction, whereas control GFP was localized in the
cytoplasm (Figure 5A). Interestingly, PH-GFP expression pre-
vented Vav1-talin assembly and talin-b1 binding promoted by
CXCL12 (Figures 5B and 5C). Furthermore, PH-GFP transfec-
tants showed a reduction in chemokine-upregulated attachmentmmunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc. 957
Figure 4. ZAP-70 Is Required for Chemokine-Promoted Vav1-Talin Dissociation and a4b1-VCAM-1 Interaction
(A) Left: Molt-4 cells preincubated in piceatannol (25 mM, 3 hr) or in carrier DMSO were exposed to CXCL12 and subjected to immunoprecipitation and
immunoblotting. Lysates from cells transfected with ZAP-70 or control siRNA were analyzed by immunoblotting with anti-ZAP-70 (middle) or subjected to
immunoprecipitation and immunoblotting (right).
(B) Piceatannol-treated cells were incubated with CXCL12 and subjected to immunoprecipitation and immunoblotting. Numbers below gels indicate values from
densitometer analyses.
(C and D) Lysates from control, talin 1, or ZAP-70 siRNA transfectants were subjected to immunoprecipitation with Vav1 or b1 mAbs, followed by immunoblotting.
(E) Cells preincubated in piceatannol or DMSO, or control or ZAP-70 siRNA transfectants were tested in adhesion assays to VCAM-1 immobilized with or without
CXCL12. ***Adhesions were significantly inhibited, p < 0.001 or **p < 0.01 (n = 3).
(F) Control or ZAP-70 siRNA transfectants were tested for 15/7 mAb (left) and VCAM-1-Fc (right) binding as stated in the legend for Figure 3.
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Figure 5. Associations between Vav1, Talin, and b1, and Chemokine-Activated Cell Adhesion Mediated by a4b1 Are Impaired by
PtdIns(4,5)P2-Sequestering Probes
(A) Molt-4 cells transfected with PH-PLC-d1-GFP (PH-GFP) or GFP vector alone were subjected to cell fractionation assays, and lysates were analyzed by
immunoblotting with antibodies to GFP, CD45 (marker for membrane fraction), or RhoGDI (marker for cytosolic fraction).
(B and C) Same transfectants were tested by immunoprecipitation with anti-Vav1 or anti-talin and subsequent immunoblotting.
(D) Transfectants were tested in static adhesion assays to VCAM-1 immobilized with or without CXCL12. **Adhesions were significantly upregulated, p < 0.01.
(E) Transfectants were incubated with or without CXCL12 or Mn2+, followed by incubation with 15/7 or control mAb and analysis by flow cytometry. Data represent
mean fluorescence intensity values from three independent experiments.
(F) Transfectants were perfused in flow chambers coated with VCAM-1 immobilized with CXCL12 and analyzed as in Figure 3. ***Adhesion was significantly
inhibited compared to GFP transfectant attachment, p < 0.001. DDTransient arrest was significantly increased compared to GFP transfectants, p < 0.01, or
Dp < 0.05.
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15/7 mAb was defective compared to control GFP counterparts,
whereas both transfectants retained similar levels of Mn2+-trig-
gered 15/7 mAb binding (Figure 5E). Control flow cytometry
experiments indicated that expression of a4 and b1 subunits
in PH-GFP transfectants was similar to control GFP counter-
parts (not shown).
Adhesion assays under shear stress revealed that PH-GFP
T cell transfectants had lower stable arrest associated with
increased transient adhesion than did GFP transfectants andIshowed higher detachment at increasing shear rates (Figure 5F).
To assess whether integrin-independent cellular functions might
be affected by PH-GFP expression, we subjected these trans-
fectants to chemotaxis toward CXCL12 across bare filters. The
results revealed that GFP and PH-GFP transfectants achieved
comparable chemotaxis (Figure S4), indicating that PH-GFP
expression is not exerting global inhibitory effects. Therefore,
PH-GFP-dependent alteration of talin association with Vav1
and b1 correlates with impairment in chemokine-stimulated
T cell adhesion mediated by a4b1, suggesting that PH-GFPmmunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc. 959
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platform that is essential for adhesion.
Role of PIPKIg90 in CXCL12-Activated Cell Adhesion
Mediated by a4b1 and in Vav1-Talin-b1 Association
Because PtdIns(4,5)P2 is synthesized by phosphatidylinositol
phosphate kinases (Ling et al., 2006), from which the PIPKIg90
isoform binds to talin (Di Paolo et al., 2002; Ling et al., 2002), we
analyzed whether overexpression of this kinase could restore
the defective adhesion seen in PH-GFP transfectants. Molt-4
cells express endogenous PIPKIg90, which associates with talin
(Figure 6A), but not with Vav1 (not shown). In addition, we found
that extent of PIPKIg90-talin association was not substantially
altered by CXCL12. Transfected PIPKIg90-GFP (KIg90-GFP)
coprecipitated with talin again independently of CXCL12 action,
whereas the mutant KIg90W647F-GFP form showed large reduc-
tion in binding to talin (Figure 6B), as earlier reported with NIH
3T3 cells (Di Paolo et al., 2002). KIg90-GFP and KIg90W647F-
GFP transfectants had a similar degree of CXCL12-activated
attachment to VCAM-1, without further activation relative to
control GFP transfectants (Figures 6C and 6D), suggesting that
PIPKIg90 endogenous activity was sufficient to stimulate adhe-
sion of both KIg90-GFP and KIg90W647F-GFP transfectants.
However, KIg90-GFP, but not the mutant kinase form, was
capable of recovering adhesion that was impaired by PH-GFP co-
transfection (Figures 6C and 6D). Constitutive Vav1-talin associa-
tion and its reduction by CXCL12, as well as stimulation of talin-b1
binding, were not altered in KIg90-GFP or KIg90W647F-GFP trans-
fectants, but again only the former showed recovery of these
dynamic associations that were abolished by PH-GFP expression
(Figures 6E and 6F). Control experiments indicated dominant
activity of KIg90-GFP over PH-GFP in CXCL12-stimulated adhe-
sion to VCAM-1 (Figure S5), suggesting that KIg90-GFP is prob-
ably competing with PH-GFP locally rather than throughout the
cell. Therefore, defective associations between Vav1, talin, and
b1 resulting from PtdIns(4,5)P2 sequestering by PH-GFP results
in failure to activate cell attachment, but local recovery of phos-
phoinositide synthesis by talin-bound KIg90-GFP would allow
correct molecular associations leading to rescue of adhesion.
A recent study showed that a RhoA-phospholipase D1 (PLD1)-
PIPKIg90 signaling module regulates LFA-1 activity in human T
lymphocytes (Bolomini-Vittori et al., 2009). Because PLD1-
derived phosphatidic acid (PA) can regulate PIPKIg90 activity
(Jarquin-Pardo et al., 2007), we studied whether PLD1 could
also control chemokine-stimulated T cell adhesion mediated
by a4b1. We addressed this question by using n-butanol, a
primary alcohol that scavenges PA produced after PLD1 activity
(Brown et al., 2007). Although n-butanol blocked CXCL12-
promoted, LFA-1-dependent Molt-4 adhesion to ICAM-1, in
agreement with previous work (Bolomini-Vittori et al., 2009), it
did not affect adhesion to VCAM-1 (Figure S6A). Control exper-
iments showed that the inactive t-butanol did not alter stimulated
adhesion to ICAM-1. In addition, binding of 15/7 mAb or VCAM-
1-Fc to Molt-4 cells exposed to CXCL12 was not affected by
n-butanol (Figure S6B). These results suggest that, contrary to
LFA-1, stimulation by chemokines of a4b1-dependent T cell
adhesion does not require PLD1 activity.
Finally, CXCL12-stimulated T cell adhesion mediated by a4b1
was not impaired by the PKC inhibitor Go¨6850 at concentrations960 Immunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc.up to 2 mM, whereas it blocked PMA-triggered adhesion
(Figure S7A). We did not use higher amounts of Go¨6850 because
it might influence the activity of other kinases. Furthermore,
Molt-4 transfectants overexpressing dominant-negative (DN)
PKC a or q isoforms (DN PKC a K368R or DN PKC q K409R)
(Baier-Bitterlich et al., 1996) attached to VCAM-1 at a similar
degree compared to wild-type counterparts upon CXCL12 stim-
ulation (Figure S7B), suggesting that PKC a or q activity is not
needed for chemokine-stimulated T cell adhesion mediated by
a4b1. A previous study reported that Go¨6850 exerted partial inhi-
bition of CXCL12-activated T cell adhesion to VCAM-1 at
concentrations of Go¨6850 of 10 mM (Ghandour et al., 2007).
The differences in concentrations together with distinct experi-
mental conditions including different time scales might account
for the different results.
DISCUSSION
When T lymphocytes become exposed to chemokines, inside-
out signals are generated that finally impinge on integrin cyto-
plasmic domains, leading to integrin activation and stimulation
of cell adhesion (Ley et al., 2007). Vav1 is a key component of
this signaling because it is required for a4b1 integrin activation
(Garcia-Bernal et al., 2005). Talin directly interacts with b subunit
integrin cytoplasmic domains and regulates integrin activation
(Tadokoro et al., 2003; Wegener et al., 2007), thereby represent-
ing a main candidate for transmission of chemokine signals.
Indeed, earlier work (Manevich et al., 2007) and our present
results demonstrate that talin is essential for chemokine-stimu-
lated T lymphocyte adhesion mediated by a4b1. Here we show
that Vav1 and talin constitutively associate in human resting T
lymphocytes and that they complex into an essential signaling
platform. Thus, when chemokine-triggered signaling converges
on this platform, Vav1 and talin gradually dissociate, represent-
ing a key event for activation of a4b1-mediated cell adhesion,
as shown in the model proposed in Figure S8. The importance
of this platform is based on the fact that silencing Vav1 or talin,
or expressing PtdIns(4,5)P2-sequestering probes, leads to
failure to assemble the complex and to a subsequent blockade
of CXCL12-stimulated T cell attachment to VCAM-1. The molec-
ular properties of Vav1-talin association, whether a direct or
indirect interaction takes place, have yet to be studied.
In addition to associate to Vav1, talin has a constitutive low
level of binding to b1, which requires Vav1 because it is absent
in Vav1-silenced cells. Therefore, a Vav1-talin-b1 complex is
formed in nonstimulated T cells, although association between
Vav1 and b1 is probably weak and occasionally difficult to
detect. Indeed, CXCL12 stimulates Vav1-b1 association with
similar kinetics as activation of talin-b1 binding, suggesting
that increased talin-b1 association might approach and favor co-
precipitation of Vav1 and b1.
PtdIns(4,5)P2 induces conformational changes on talin, lead-
ing to increased talin affinity for b1 integrins (Martel et al.,
2001). PtdIns(4,5)P2 is mainly synthesized by type I phosphatidy-
linositol phosphate kinases (Ling et al., 2006), from which
PIPKIg90 is able to bind to talin, resulting in increased kinase
activity (Di Paolo et al., 2002; Ling et al., 2002). We found that
PIPKIg90 is expressed on T cells and that it associates with talin.
Moreover, overexpressed PIPKIg90-GFP, but not the mutant
Figure 6. Overexpression of PIPKIg90 Overcomes PH-GFP-Dependent Blockade of Associations between Vav1, Talin, and b1, as well as
a4b1-Mediated T Cell Adhesion
(A and B) Untransfected (A) or Molt-4 cells transfected with PIPKIg90-GFP, PIPKIg90W647F-GFP, or GFP vector alone (B) were incubated with CXCL12 and
subsequently subjected to immunoprecipitation with anti-PIPKIg90 or anti-talin and immunoblotting with antibodies to the indicated proteins. Total expression
of PIPKIg90-GFP and PIPKIg90W647F-GFP was assessed by immunoblotting (B, right).
(C and D) Cells were transfected with PIPKIg90-GFP or PIPKIg90W647F-GFP alone or in combination with PH-GFP, and subsequently tested in static adhesion
assays to VCAM-1 immobilized with or without CXCL12 (C), or in flow chamber adhesion assays (D) measuring interacting cells (left) or shear resistance (right).
***Adhesions were significantly increased, p < 0.001, **p < 0.01, or *p < 0.05, or inhibited AAAp < 0.001. DTransient arrest was significantly increased, p < 0.05.
(E and F) Same transfectants were incubated with CXCL12, followed by immunoprecipitation with Vav1 or b1 mAb and immunoblotting with antibodies to the
indicated proteins.
Immunity
Vav1-Talin Dissociation Controls T Cell AdhesionPIPKIg90W647F-GFP form, bound to talin and rescued talin asso-
ciation with Vav1 and b1 from the PH-GFP inhibitory effects.
Both PIPKIg90 and b1 interact with overlapping sites on the F3
subdomain of the FERM talin domain (Barsukov et al., 2003),
suggesting that binding is mutually exclusive. PIPKIg90 associ-Iates with talin but not with Vav1 and CXCL12 does not trigger ta-
lin release from PIPKIg90, so we propose that local production of
PtdIns(4,5)P2 by talin-bound PIPKIg90 promotes assembly and/
or stabilization of nearby Vav1-talin complexes, in addition
to stimulating constitutive talin-b1 association. Constitutivemmunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc. 961
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Vav1-Talin Dissociation Controls T Cell Adhesionb1-associated talin in nonstimulated T cells might function as the
ground pool for promoting future tethers in a PtdIns(4,5)P2-
dependent manner. An important role for PIPKIg90 has also
been recently proposed during chemokine-stimulated T cell
adhesion mediated by LFA-1 (Bolomini-Vittori et al., 2009).
Increased talin-a4b1 binding and Vav1 dissociation from talin
in response to CXCL12 are required dynamic steps for stimula-
tion of aa4bb1 activation (Figures S8B and S8C). Upregulation
of talin-b1 binding needs preformed Vav1-talin complex, but it
is independent of Vav1 dissociation from talin, suggesting that
it occurs before Vav1-talin disassembly. The molecular events
underlying CXCL12-stimulated talin-b1 binding are not known
but they might include a better access of the complex to
PtdIns(4,5)P2 resulting from chemokine actions. Stimulation by
CXCL12 of talin binding to a4b1 is critical but not sufficient to
fully activate the integrin, because it requires ZAP-70-dependent
subsequent dissociation of Vav1 from talin for further integrin
activation, as detected with 15/7 anti-b1 mAb, a reporter of
a4b1 activation. ZAP-70 is recruited and binds to Vav1 in pre-
formed Vav1-talin complexes upon chemokine stimulation, as
indicated by the fact that it does not occur in talin-silenced cells.
A potential mediator of ZAP-70 recruitment is Lck, which is
a target of CXCL12 signaling (Inngjerdingen et al., 2002) and
tyrosine phosphorylates ZAP-70. Earlier work demonstrated
that ZAP-70 is involved in Vav1 tyrosine phosphorylation in
response to CXCL12 (Ottoson et al., 2001). Our results indicate
that ZAP-70 binding to Vav1-talin complexes leads to Vav1
phosphorylation, which possibly weakens Vav1-talin associa-
tion. Therefore, our data strongly suggest that chemokine-
promoted, ZAP-70-dependent phosphorylation of Vav1 starts
while associated with talin in the signaling platform. This conclu-
sion is based on the following results. Talin silencing or PH-GFP
expression blocks both formation of Vav1-talin complex and
subsequent Vav1 phosphorylation. Furthermore, talin knock-
down impairs Vav1-ZAP-70 binding, and inhibition of ZAP-70
activity abolishes chemokine-dependent Vav1 phosphorylation
associated with blocking of Vav1-talin disassembly. Although
this phosphorylation is difficult to detect at early time points in
Molt-4 cells, results with PBL-T cells together with the above
observations indeed indicate that phosphorylation occurs in
Vav1-talin complexes, and thus, talin functions as a modulator
of Vav1 tyrosine phosphorylation. Together, our data suggest
that Vav1 functions as a constitutive repressive adaptor of talin
that needs to be phosphorylated in order to be released from
a4b1-talin complexes and render talin available for additional
b1 integrin activation. It is noteworthy that the talin pool recently
dissociated from Vav1 after chemokine-ZAP-70 signals may be
involved in a4b1 activation seconds after the first chemokine
signal is transduced, and it could also contribute to strength-
ening of attachment at later times in the adhesion process.
According to the present data, it is therefore unlikely that pre-
existing a4b1 high-affinity molecules, or clustered a4b1 hetero-
dimers after ligand binding that are engaged in outside-in
signaling, could be associated to the Vav1-talin platform.
CXCL12-triggered phosphorylation of Vav1 is essential for
Rac1 activation and progression of a4b1-mediated T cell adhe-
sion (Garcia-Bernal et al., 2005). An additional consequence of
deficient Vav1 phosphorylation in talin-silenced cells was the
impairment of Rac1 activation. The kinetics of Rac1 activation962 Immunity 31, 953–964, December 18, 2009 ª2009 Elsevier Inc.in response to CXCL12 indicate that this is a late signaling
event mediating stimulation of a4b1-dependent cell adhesion
strengthening, rather than involvement in a4b1 activation (Figure
S8C). Further adhesion strengthening might come from
CXCL12-stimulated binding of vinculin to talin, which might be
based on promotion of PtdIns(4,5)P2-mediated opening of the
head-tail vinculin interaction (Gilmore and Burridge, 1996) or talin
rod stretching exposing buried vinculin-binding sites (del Rio
et al., 2009).
Monocyte adhesion mediated by a4b1 is also tightly controlled
by chemokines (Chan et al., 2001). The Syk kinase is expressed
in monocytes instead of ZAP-70, which is highly specific of
T cells. Syk interacts with and tyrosine phosphorylates Vav
proteins (Deckert et al., 1996), thus raising the possibility that
a similar pathway of early chemokine-dependent activation of
a4b1 involving Syk-Vav1 might occur in monocytes. It is note-
worthy that phospholipase C mediates a4b1 activation in re-
sponse to chemokines in monocytes (Hyduk et al., 2007).
Thus, although ZAP-70 and Syk could have parallel roles in
Vav activation, the involvement of PLC in a4b1 activation may
be restricted to monocytes.
Paxillin binds to the cytoplasmic domain of a4 (Liu et al., 1999),
modulating adhesion strengthening to a4b1 ligands (Alon et al.,
2005). However, recent data showed that paxillin is not involved
in chemokine-stimulated adhesion mediated by a4b1 (Manevich
et al., 2007). Instead, Rap1 and kindlin-3 control chemokine-
promoted T cell adhesion involving a4b1 and LFA-1 (Moser
et al., 2009; Shimonaka et al., 2003). It will be important to inves-
tigate potential structural and functional cross-talks between
the Vav1-talin signaling platform and Rap1 and kindlin-3 in
chemokine-triggered a4b1-dependent adhesion. Because a4b1
function is fundamental for T lymphocyte arrest on endothelium
after chemokine stimulation at sites of inflammation (Luster et al.,
2005), the present results should contribute to a better definition
of the dynamic associations between components of the
signaling machinery associated to a4b1 activation.
EXPERIMENTAL PROCEDURES
Cells and Antibodies
Human Molt-4 T cells and peripheral blood T lymphocytes were cultured and
prepared as described (Garcia-Bernal et al., 2005). The Consejo Superior de
Investigaciones Cientificas Ethics Committee (Madrid, Spain) approved the
protocols used to obtain and process the human samples. Control P3X63,
a4 HP1/2, b1 TS2/16, and CD45 RP2/21 mAb were gifts from F. Sa´nchez-
Madrid (Hospital de la Princesa, Madrid, Spain). Polyclonal b1A antibodies
and the b1 mAb 15/7 were gifts from G. Tarone and R. Alon (Turin University,
Italy; Weizmann Institute of Science, Rehovot, Israel, respectively), whereas
PIPKIg90 antibodies were from P. De Camilli (Yale University, New Haven,
CT). CXCR4 mAb was from R&D Systems (Minneapolis, MN); phosphotyro-
sine, Vav1, RhoGDI, and a4 antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA); anti-Rac1 was from BD Biosciences PharMingen (San Diego,
CA); anti-GFP was from Molecular Probes (Eugene, OR); and anti-vinculin
and anti-talin clone 8D4 were from Sigma-Aldrich (St Louis, MO). Antibodies
to ZAP-70 were from J.M. Rojo (Centro de Investigaciones Biolo´gicas, Madrid,
Spain).
Transfections and RNA Interference
Vector coding for GFP-fused PH domain of PLC-d1 was from M.J. Rebecchi
(State University of New York, NY), whereas PIPKIg90-GFP and PIPKIg90-
W647F-GFP vectors were obtained from P. De Camilli. GFP-fused Vav1
wild-type and the mutant Vav1 DCH+Ac vectors were from X. Bustelo (Centro
Immunity
Vav1-Talin Dissociation Controls T Cell Adhesionde Investigacio´n del Ca´ncer, Salamanca, Spain). Three independent siRNA
duplexes against human talin 1 were purchased from Ambion (Austin, TX).
One of them strongly inhibited talin 1 expression and was labeled as i-talin 1
(interfering-talin 1); the other two showed little or no inhibition of talin 1 expres-
sion and they were presented as ni-talin 1 (noninterfering-talin 1) (see
Figure 1C). ZAP-70 siRNA was purchased from Dharmacon (Lafayette, CO),
and control and Vav1 siRNA (Vav1.3) were as reported (Garcia-Bernal et al.,
2005). Vectors and siRNA were nucleofected according to the described
procedure (Garcia-Bernal et al., 2005). Molt-4 or PBL-T siRNA transfectants
were assayed 16 hr or 6 hr posttransfection, respectively.
Cell Adhesion and Soluble Binding Assays
For static cell adhesion to VCAM-1 alone or immobilized with CXCL12 (R&D
Systems), we used the described method (Garcia-Bernal et al., 2005). Extent
of adhesion was quantified with a fluorescence analyzer (for siRNA transfec-
tants) or by flow cytometry (GFP transfectants). For flow chamber adhesion
assays, we followed the reported protocol (Garcia-Bernal et al., 2006). In brief,
transfectants were infused into flow chambers containing coimmobilized
VCAM-1 and CXCL12. Rolling cells firmly attaching for at least 20 s were
expressed as stable arrest, whereas cells attaching for a maximum of 5 s
but resuming rolling were expressed as transient arrest. Otherwise, tethering
cells that did not arrest at any moment were expressed as rolling cells. To eval-
uate shear resistance, cells were allowed to attach, followed by sequential
increases of the flow. The number of cells remaining bound was determined
as the percentage of total adhered cells after the adhesion step. For soluble
binding, transfectants were stimulated for 45 s with CXCL12 or MnCl2 before
adding VCAM-1-Fc, which was detected by flow cytometry (Garcia-Bernal
et al., 2005). Before addition of the 15/7 mAb, cells were exposed to
CXCL12 or MnCl2 for 1 min.
Immunoprecipitation, Immunoblotting, Cell Fractionation,
and GTPase Assays
For immunoprecipitation, Molt-4 (23 107) and PBL-T (53 107) cells were lysed
with 1% digitonin as reported (Ticchioni et al., 2002). After preclearing with
protein G-sepharose (Amersham Pharmacia Biotech, Uppsala, Sweden),
supernatants were incubated with antibodies, followed by coupling to protein
G-sepharose beads. Proteins were resolved by SDS-PAGE and transferred to
membranes that were sequentially incubated with primary antibodies and with
horseradish peroxidase-conjugated secondary antibodies. Proteins were
visualized with SuperSignal chemiluminiscent substrate (Pierce, Rockford, IL).
For cell fractionation, cells (33 106) were incubated at 4C with 100 ml of hypo-
tonic digitonin buffer, as described (Redondo-Munoz et al., 2006). In brief,
cytosolic and membrane fractions were separated by centrifugation and the
pellet was extracted with NP-40 lysis buffer whereas lysates were clarified
by centrifugation. Protein detection was performed as above. For GTPase
assays, we followed the method described (Garcia-Bernal et al., 2005). In brief,
cells exposed to CXCL12 were lysed and aliquots from extracts were sepa-
rated for total lysate controls and for incubation with GST-PAK-CD fusion
protein (Sander et al., 1998) and glutathione-agarose beads. Bound proteins
were eluted and subjected to immunoblotting via Rac1 antibodies.
Statistical Analyses
Data were analyzed by one-way analysis of variance (ANOVA), followed by
Tukey-Kramer multiple comparisons. In both analyses, the minimum accept-
able level of significance was p < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include eight figures and can be found with this article online
at http://www.cell.com/immunity/supplemental/S1074-7613(09)00499-3.
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